Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Manisha Bhutani

Showing results (1-10 of 99) with videos related to

Pageof 10
Sort By:
Transplantation and Cellular Therapy|August 25, 2023
Boosting CAR T cytopenias with backup autologous stem cellsManisha Bhutani
The National Medical Journal of India|September 18, 2004
The place of preoperative chemotherapy in breast cancerManisha Bhutani, Vinod Raina
Cells|July 25, 2025
Resistance Mechanisms to BCMA Targeting Bispecific Antibodies and CAR T-Cell Therapies in Multiple MyelomaBrandon Tedder, Manisha Bhutani
Journal of the National Cancer Institute|September 11, 2008
Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Manisha Bhutani, Ashutosh Kumar Pathak
Lancet (London, England)|December 15, 2019
Quadruplets come of age for newly diagnosed multiple myelomaManisha Bhutani, Saad Z Usmani
Frontiers in Oncology|June 5, 2024
Mechanisms and management of CAR T toxicityChristopher J Ferreri, Manisha Bhutani
Journal of the National Medical Association|December 24, 2022
Disparities in multiple myeloma among African AmericansManisha Bhutani, Sagar Lonial, Joseph Mikhael
Indian Journal of Dermatology, Venereology and Leprology|January 6, 2006
Generalized hypopigmentation due to imatinib: a fairness boon?Atul Sharma, Amish Vora, Manisha Bhutani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
SWOG S0023: what meets the eye may be only half the truthManisha Bhutani, Ashutosh K Pathak, Li Mao
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Multiple myeloma: is it time for biomarker-driven therapy?Manisha Bhutani, Ola Landgren, Saad Z Usmani
Pageof 10

Showing results (1-10 of 99) with videos related to

Sort By:
Pageof 10
Transplantation and Cellular Therapy|August 25, 2023
Boosting CAR T cytopenias with backup autologous stem cellsManisha Bhutani
The National Medical Journal of India|September 18, 2004
The place of preoperative chemotherapy in breast cancerManisha Bhutani, Vinod Raina
Cells|July 25, 2025
Resistance Mechanisms to BCMA Targeting Bispecific Antibodies and CAR T-Cell Therapies in Multiple MyelomaBrandon Tedder, Manisha Bhutani
Journal of the National Cancer Institute|September 11, 2008
Re: Should supplemental antioxidant administration be avoided during chemotherapy and radiation therapy?Manisha Bhutani, Ashutosh Kumar Pathak
Lancet (London, England)|December 15, 2019
Quadruplets come of age for newly diagnosed multiple myelomaManisha Bhutani, Saad Z Usmani
Frontiers in Oncology|June 5, 2024
Mechanisms and management of CAR T toxicityChristopher J Ferreri, Manisha Bhutani
Journal of the National Medical Association|December 24, 2022
Disparities in multiple myeloma among African AmericansManisha Bhutani, Sagar Lonial, Joseph Mikhael
Indian Journal of Dermatology, Venereology and Leprology|January 6, 2006
Generalized hypopigmentation due to imatinib: a fairness boon?Atul Sharma, Amish Vora, Manisha Bhutani
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 10, 2008
SWOG S0023: what meets the eye may be only half the truthManisha Bhutani, Ashutosh K Pathak, Li Mao
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 21, 2015
Multiple myeloma: is it time for biomarker-driven therapy?Manisha Bhutani, Ola Landgren, Saad Z Usmani
Pageof 10